Lunai Bioworks Inc. SEC filings LNAI

Lunai Bioworks Inc. has 599 filings in SEC EDGAR's recent list, going back to Aug 12, 2011. Its latest annual report, Form 10-K, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (listing notice, officer or director change, regulation fd disclosure, other events). The company's fiscal year ends on June 30.

Lunai Bioworks Inc. SEC filings
Form Description Filed Period
25 Form 25 Nov 2, 2026 —
EFFECT Filing Oct 26, 2026 —
S-8 POS Form s-8 pos Oct 23, 2026 —
POS AM Form pos am Oct 23, 2026 —
S-8 POS Form s-8 pos Oct 23, 2026 —
8-K Current report
Listing notice, Officer or director change, Regulation FD disclosure, Other events
Oct 23, 2026 Oct 16, 2026
10-K Annual report Oct 13, 2026 Jun 30, 2026
8-K Current report
Other events
Oct 9, 2026 Oct 9, 2026
NT 10-K Form nt 10-k Sep 29, 2026 Jun 30, 2026
8-K Current report
Other events
Jun 17, 2026 Jun 17, 2026
8-K Current report
Other events
Jun 16, 2026 Jun 11, 2026
8-K Current report
Other events
May 20, 2026 May 20, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Shareholder vote results
May 13, 2026 May 8, 2026
8-K/A Amended current report
Listing notice
May 11, 2026 Apr 27, 2026
DEFR14A Form defr14a May 1, 2026 —
8-K Current report
Material agreement, Acquisition or sale of assets, Listing notice, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
May 1, 2026 Apr 27, 2026
8-K Current report
Other events
Apr 28, 2026 Apr 27, 2026
DEFA14A Additional proxy material Apr 28, 2026 —
DEFR14A Form defr14a Apr 15, 2026 —
DEF 14A Proxy statement Apr 13, 2026 Apr 13, 2026
PRE 14A Preliminary proxy statement Apr 2, 2026 Apr 2, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 30, 2026 Mar 24, 2026
8-K Current report
Other events
Mar 5, 2026 Feb 27, 2026
8-K Current report
Listing notice
Feb 23, 2026 Feb 17, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
8-K Current report
Listing notice, Regulation FD disclosure
Feb 12, 2026 Feb 6, 2026
424B5 Prospectus supplement Dec 3, 2025 —
8-K Current report
Material agreement
Dec 3, 2025 Dec 2, 2025
8-K Current report
Unregistered share sale
Nov 25, 2025 Nov 25, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Listing notice
Nov 6, 2025 Nov 4, 2025
8-K Current report
Shareholder vote results
Nov 3, 2025 Oct 31, 2025
8-K Current report
Listing notice
Oct 30, 2025 Oct 27, 2025
8-K Current report
Listing notice
Oct 16, 2025 Oct 15, 2025
DEF 14A Proxy statement Oct 15, 2025 Oct 15, 2025
10-K Annual report Sep 29, 2025 Jun 30, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 24, 2025 Sep 18, 2025
8-K Current report
Impairment, Other events
Sep 5, 2025 Sep 2, 2025
8-K Current report
Bylaw or fiscal year change
Aug 26, 2025 Aug 26, 2025
8-K Current report
Listing notice
Aug 6, 2025 Aug 6, 2025
DEF 14A Proxy statement Jul 30, 2025 Jul 30, 2025
8-K Current report
Officer or director change
Jul 25, 2025 Jul 25, 2025
PRE 14A Preliminary proxy statement Jul 18, 2025 Jul 18, 2025
8-K Current report
Listing notice
Jul 14, 2025 Jul 14, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 9, 2025 Jul 9, 2025
8-K Current report
Officer or director change
Jun 5, 2025 May 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Listing notice
Apr 18, 2025 Apr 14, 2025
8-K Current report
Unregistered share sale, Other events
Apr 10, 2025 Apr 8, 2025
425 Form 425 Mar 6, 2025 —
8-K Current report
Material agreement
Mar 6, 2025 Feb 28, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 28, 2025 Feb 26, 2025
10-Q Quarterly report Feb 19, 2025 Dec 31, 2024
10-Q/A Amended quarterly report Feb 19, 2025 Sep 30, 2024
10-K/A Amended annual report Feb 19, 2025 Jun 30, 2024
10-Q/A Amended quarterly report Feb 19, 2025 Mar 31, 2024
8-K Current report
Restatement
Feb 19, 2025 Feb 18, 2025
NT 10-Q Form nt 10-q Feb 18, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Feb 10, 2025 Feb 4, 2025
8-K Current report
Officer or director change
Jan 13, 2025 Jan 6, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jan 7, 2025 Jan 1, 2025
8-K Current report
Officer or director change
Jan 6, 2025 Dec 30, 2024
8-K Current report
Officer or director change
Nov 21, 2024 Nov 15, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Nov 8, 2024 Nov 4, 2024
EFFECT Filing Nov 6, 2024 —
CORRESP Letter to the SEC Nov 4, 2024 —
UPLOAD Letter from the SEC Nov 4, 2024 —
S-3 Shelf registration Oct 30, 2024 —
8-K/A Amended current report
Officer or director change
Oct 29, 2024 Oct 11, 2024
10-K/A Amended annual report Oct 28, 2024 Jun 30, 2024
8-K Current report
Listing notice
Oct 16, 2024 Oct 11, 2024
10-K Annual report Oct 10, 2024 Jun 30, 2024
UPLOAD Letter from the SEC Oct 10, 2024 —
NT 10-K Form nt 10-k Oct 1, 2024 Jun 30, 2024
CORRESP Letter to the SEC Oct 1, 2024 —
UPLOAD Letter from the SEC Sep 25, 2024 —
8-K Current report
Listing notice
Sep 17, 2024 Sep 12, 2024
8-K Current report
Other events
Sep 11, 2024 Sep 11, 2024
10-Q/A Amended quarterly report Aug 20, 2024 Mar 31, 2024
8-K Current report
Restatement, Regulation FD disclosure
Aug 19, 2024 Aug 14, 2024
CORRESP Letter to the SEC Aug 16, 2024 —
UPLOAD Letter from the SEC Jul 12, 2024 —
8-K Current report
Officer or director change
Jul 3, 2024 Jun 27, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 21, 2024 Jun 14, 2024
CORRESP Letter to the SEC May 31, 2024 —
8-K Current report
Bylaw or fiscal year change
May 24, 2024 May 21, 2024
8-K Current report
Other events
May 24, 2024 May 24, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Other events
Apr 30, 2024 Apr 30, 2024
8-K Current report
Other events
Apr 25, 2024 Apr 24, 2024
8-K/A Amended current report Apr 24, 2024 Feb 9, 2024
UPLOAD Letter from the SEC Apr 22, 2024 —
8-K Current report
Officer or director change
Mar 13, 2024 Mar 11, 2024
CORRESP Letter to the SEC Mar 11, 2024 —
8-K Current report
Agreement ended
Mar 7, 2024 Mar 1, 2024
8-K Current report
Officer or director change
Mar 5, 2024 Feb 28, 2024
D Filing Feb 23, 2024 —
8-K Current report
Other events
Feb 16, 2024 Feb 16, 2024
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Feb 14, 2024 Feb 9, 2024
8-K Current report
Bylaw or fiscal year change
Feb 7, 2024 Feb 1, 2024
UPLOAD Letter from the SEC Jan 30, 2024 —
8-K Current report
Shareholder vote results, Other events
Jan 25, 2024 Jan 25, 2024
DEFA14A Additional proxy material Jan 16, 2024 —
8-K Current report
Other events
Jan 16, 2024 Jan 16, 2024
8-K Current report
Other events
Jan 16, 2024 Jan 16, 2024
DEFA14A Additional proxy material Jan 16, 2024 —
DEFM14A Form defm14a Jan 3, 2024 —
PREM14A Filing Dec 22, 2023 Dec 22, 2023
DEFA14A Additional proxy material Dec 22, 2023 —
DEFA14A Additional proxy material Dec 11, 2023 —
DEFA14A Additional proxy material Dec 7, 2023 —
DEFA14A Additional proxy material Dec 1, 2023 —
DEFA14A Additional proxy material Dec 1, 2023 —
8-K Current report
Regulation FD disclosure
Dec 1, 2023 Dec 1, 2023
DEFA14A Additional proxy material Nov 22, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
DEFA14A Additional proxy material Nov 2, 2023 —
10-K/A Amended annual report Oct 30, 2023 Jun 30, 2023
S-8 Employee stock plan registration Oct 23, 2023 —
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Oct 11, 2023 Oct 10, 2023
DEFA14A Additional proxy material Oct 11, 2023 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Oct 10, 2023 Oct 5, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 10, 2023 Oct 4, 2023
DEFA14A Additional proxy material Oct 10, 2023 —
DEFA14A Additional proxy material Oct 4, 2023 —
DEFA14A Additional proxy material Oct 4, 2023 —
425 Form 425 Oct 2, 2023 —
8-K Current report
Other events
Oct 2, 2023 Oct 2, 2023
10-K Annual report Oct 2, 2023 Jun 30, 2023
425 Form 425 Sep 29, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 29, 2023 Sep 28, 2023
NT 10-K Filing Sep 29, 2023 Jun 30, 2023
8-K Current report
Regulation FD disclosure
Aug 9, 2023 Aug 9, 2023
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Aug 7, 2023 Aug 1, 2023
8-K Current report
Bylaw or fiscal year change
Aug 7, 2023 Aug 1, 2023
8-K Current report
Shareholder vote results
Jul 28, 2023 Jul 21, 2023
8-K Current report
Listing notice
Jul 11, 2023 Jul 7, 2023
DEFA14A Additional proxy material Jul 10, 2023 —
8-K Current report
Bylaw or fiscal year change
Jul 10, 2023 Jul 7, 2023
8-K Current report
Material agreement, Unregistered share sale
Jun 28, 2023 Jun 26, 2023
8-K Current report
Material agreement
Jun 27, 2023 Jun 20, 2023
DEFA14A Additional proxy material Jun 23, 2023 —
8-K Current report
Shareholder vote results, Other events
Jun 23, 2023 Jun 22, 2023
UPLOAD Letter from the SEC Jun 9, 2023 —
8-K Current report
Other events
Jun 8, 2023 Jun 8, 2023
DEF 14A Proxy statement May 16, 2023 May 15, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Other events
May 5, 2023 May 5, 2023
8-K Current report
Material agreement, Unregistered share sale
Apr 3, 2023 Mar 30, 2023
8-K Current report
Other events
Mar 29, 2023 Mar 29, 2023
8-K Current report
Other events
Mar 13, 2023 Mar 13, 2023
10-Q Quarterly report Mar 9, 2023 Dec 31, 2022
10-Q Quarterly report Mar 7, 2023 Sep 30, 2022
10-K Annual report Feb 27, 2023 Jun 30, 2022
8-K Current report
Material agreement, Listing notice, Regulation FD disclosure
Feb 23, 2023 Feb 16, 2023
8-K Current report
Other events
Dec 30, 2022 Dec 27, 2022
8-K Current report
Officer or director change
Dec 16, 2022 Oct 18, 2022
8-K Current report
Listing notice, Regulation FD disclosure
Nov 30, 2022 Nov 23, 2022
NT 10-Q Form nt 10-q Nov 15, 2022 Sep 30, 2022
8-K Current report
Other events
Oct 24, 2022 Oct 24, 2022
8-K Current report
Listing notice, Regulation FD disclosure
Oct 21, 2022 Oct 17, 2022
8-K Current report
Other events
Oct 17, 2022 Oct 17, 2022
NT 10-K Form nt 10-k Sep 29, 2022 Jun 30, 2022
8-K Current report
Other events
Sep 23, 2022 Sep 23, 2022
8-K Current report
Other events
Jul 6, 2022 Jul 6, 2022
8-K Current report
Other events
Jul 1, 2022 Jul 1, 2022
8-K Current report
Other events
Jun 7, 2022 Jun 6, 2022
8-K Current report
Other events
Jun 2, 2022 Jun 1, 2022
8-K Current report
Other events
May 31, 2022 May 31, 2022
8-K Current report
Other events
May 26, 2022 May 25, 2022
8-K Current report
Regulation FD disclosure
May 24, 2022 May 24, 2022
8-K Current report
Other events
May 18, 2022 May 17, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Other events
Apr 20, 2022 Apr 20, 2022
8-K Current report
Other events
Apr 7, 2022 Apr 7, 2022
8-K Current report
Other events
Apr 5, 2022 Apr 5, 2022
8-K Current report
Officer or director change
Mar 29, 2022 Mar 25, 2022
8-K Current report
Shareholder vote results
Mar 16, 2022 Mar 14, 2022
8-K Current report
Other events
Mar 15, 2022 Mar 15, 2022
EFFECT Filing Mar 8, 2022 —
CORRESP Letter to the SEC Mar 4, 2022 —
S-3/A Form s-3/a Mar 3, 2022 —
UPLOAD Letter from the SEC Feb 18, 2022 —
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
S-3 Shelf registration Feb 11, 2022 —
DEFA14A Additional proxy material Jan 28, 2022 —
DEFA14A Additional proxy material Jan 28, 2022 —
DEF 14A Proxy statement Jan 27, 2022 Jan 28, 2022
8-K Current report
Other events
Jan 24, 2022 Jan 24, 2022
8-K Current report
Regulation FD disclosure
Dec 22, 2021 Dec 22, 2021
S-8 Employee stock plan registration Dec 13, 2021 —
8-K Current report
Regulation FD disclosure
Dec 1, 2021 Dec 1, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-K/A Amended annual report Oct 28, 2021 Jun 30, 2021
10-K Annual report Sep 24, 2021 Jun 30, 2021
8-K Current report
Regulation FD disclosure
Sep 13, 2021 Sep 13, 2021
8-K Current report
Other events
Aug 30, 2021 Aug 30, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LNAI (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Suite 906 Los Angeles, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1527728
Former names
RENOVARO INC. (until Aug 26, 2025); RENOVARO BIOSCIENCES INC. (until Feb 7, 2024); Enochian Biosciences Inc (until Aug 1, 2023); DanDrit Biotech USA, Inc. (until Feb 23, 2018); Putnam Hills Corp. (until Feb 11, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.